These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 11920570

  • 61. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
    George TC, Bilsborough J, Viney JL, Norment AM.
    Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
    [Abstract] [Full Text] [Related]

  • 62. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB, Eriksson K, Li BL, Lindblad M, Azem J, Holmgren J.
    Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
    [Abstract] [Full Text] [Related]

  • 63. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
    Hermans IF, Ritchie DS, Daish A, Yang J, Kehry MR, Ronchese F.
    J Immunol; 1999 Jul 01; 163(1):77-81. PubMed ID: 10384102
    [Abstract] [Full Text] [Related]

  • 64. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
    Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F.
    J Immunol; 2000 Mar 15; 164(6):3095-101. PubMed ID: 10706699
    [Abstract] [Full Text] [Related]

  • 65. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 May 15; 41(6):1410-21. PubMed ID: 10798657
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. GIF inhibits Th effector generation by acting on antigen-presenting B cells.
    Sugie K, Huang J.
    J Immunol; 2001 Apr 01; 166(7):4473-80. PubMed ID: 11254703
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen.
    Setoguchi K, Misaki Y, Araki Y, Fujio K, Kawahata K, Kitamura T, Yamamoto K.
    J Immunol; 2000 Nov 15; 165(10):5980-6. PubMed ID: 11067961
    [Abstract] [Full Text] [Related]

  • 75. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
    Schulz O, Pennington DJ, Hodivala-Dilke K, Febbraio M, Reis e Sousa C.
    J Immunol; 2002 Jun 15; 168(12):6057-65. PubMed ID: 12055214
    [Abstract] [Full Text] [Related]

  • 76. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y, Zhang J, Mi Z, Robbins P, Falo LD.
    J Immunol; 2005 Mar 15; 174(6):3808-17. PubMed ID: 15749922
    [Abstract] [Full Text] [Related]

  • 77. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL.
    Luketic L, Delanghe J, Sobol PT, Yang P, Frotten E, Mossman KL, Gauldie J, Bramson J, Wan Y.
    J Immunol; 2007 Oct 15; 179(8):5024-32. PubMed ID: 17911587
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.